Argatroban as a substitute for heparin during VAIVT for a patient with heparin-induced thrombocytopenia

DOI Web Site Web Site 9 References Open Access
  • Sangawa Kenji
    Department of Cardiovascular Surgery, Matsuyama Shimin Hospital
  • Sekikawa Takashi
    Division of Nephrology, Department of Internal Medicine, Matsuyama Shimin Hospital

Bibliographic Information

Other Title
  • アルガトロバンを使用して内シャント経皮的血管形成術 (VAIVT) を行ったヘパリン起因性血小板減少症 (HIT) の1例
  • 症例報告 アルガトロバンを使用して内シャント経皮的血管形成術(VAIVT)を行ったヘパリン起因性血小板減少症(HIT)の1例
  • ショウレイ ホウコク アルガトロバン オ シヨウ シテ ナイ シャント ケイヒテキ ケッカン ケイセイジュツ(VAIVT)オ オコナッタ ヘパリン キインセイ ケッショウバン ゲンショウショウ(HIT)ノ 1レイ

Search this article

Description

<p>Hemodialysis using heparin can cause HIT. For patients with HIT, heparin cannot be used to treat vascular access failure. An 80-year-old woman exhibiting swelling of her right arm and an arterio-venous graft was diagnosed with HIT one month after starting hemodialysis. Her venous pressure during hemodialysis was high. Argatroban was used during VAIVT to treat repeated vascular access failure four times. Her postoperative course was uneventful. For patients with HIT, argatroban can be used as a substitute for heparin to treat vascular access failure.</p>

Journal

References(9)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top